Skip to main navigation Skip to search Skip to main content

Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria

  • Rachael Milligan
  • , André Daher
  • , Patricia M Graves
  • Liverpool School of Tropical Medicine

Research output: Contribution to journalArticlepeer-review

14 Citations (Scopus)

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:

To assess the efficacy and safety of alternative primaquine regimens for radical cure ofP. vivax malaria compared to the standard 14 days of primaquine 0.25 mg/kg/day.

Original languageEnglish
Article numberCD012656
Pages (from-to)CD012656
JournalCochrane Database of Systematic Reviews
Volume2017
Issue number5
DOIs
Publication statusPublished - 4 May 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria'. Together they form a unique fingerprint.

Cite this